屋漏偏逢连夜雨，风电巨头暴跌夯实丹麦“全球表现最差股市”

Group 1 - The OMX Copenhagen 25 Index (OMXC25), which includes Denmark's 25 largest stocks, has fallen by 7.5% year-to-date and has dropped 20% from its one-year high [1] - Denmark's stock index is the worst-performing developed market benchmark this year, while the Stoxx Europe 600 Index and the S&P 500 Index have both risen nearly 8% [3] - Major Danish companies are facing various crises, with Ørsted, a leading offshore wind power company, announcing a capital increase plan of up to 60 billion Danish kroner (approximately 67.1 billion RMB), leading to a record single-day stock price drop of 29% [4][6] Group 2 - Ørsted's capital increase is a response to the impact of U.S. policies under the Trump administration, which halted offshore wind project permits and reduced tax credits for the industry [6] - Novo Nordisk, Denmark's largest company, has also faced a significant stock price drop due to increased competition in the weight-loss drug market and challenges in the profitable U.S. market [6] - The decline in major stocks has severely impacted household wealth in Denmark, with a single-day drop in Novo Nordisk's stock on July 29 resulting in a loss of 38 billion Danish kroner for ordinary Danish stock portfolios, equivalent to 3% of the country's annual private consumption [8] Group 3 - Other companies in the Danish benchmark index have also seen significant declines, with Zealand Pharma down over 50%, Pandora down 20% due to U.S. tariff concerns, and Coloplast down over 20% after the CEO was dismissed [8]